Literature DB >> 33128861

Animal models for SARS-CoV-2 research: A comprehensive literature review.

Kabita Pandey1,2, Arpan Acharya1, Mahesh Mohan3, Caroline L Ng2, St Patrick Reid2, Siddappa N Byrareddy1,4,5.   

Abstract

Emerging and re-emerging viral diseases can create devastating effects on human lives and may also lead to economic crises. The ongoing COVID-19 pandemic due to the novel coronavirus (nCoV), severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which originated in Wuhan, China, has caused a global public health emergency. To date, the molecular mechanism of transmission of SARS-CoV-2, its clinical manifestations and pathogenesis is not completely understood. The global scientific community has intensified its efforts in understanding the biology of SARS-CoV-2 for development of vaccines and therapeutic interventions to prevent the rapid spread of the virus and to control mortality and morbidity associated with COVID-19. To understand the pathophysiology of SARS-CoV-2, appropriate animal models that mimic the biology of human SARS-CoV-2 infection are urgently needed. In this review, we outline animal models that have been used to study previous human coronaviruses (HCoVs), including severe acute respiratory syndrome coronavirus (SARS-CoV) and middle east respiratory syndrome coronavirus (MERS-CoV). Importantly, we discuss models that are appropriate for SARS-CoV-2 as well as the advantages and disadvantages of various available methods.
© 2020 Wiley-VCH GmbH.

Entities:  

Keywords:  SARS-CoV-2; animal model; ferret; hamster; macaque; mice; pathophysiology

Mesh:

Year:  2020        PMID: 33128861      PMCID: PMC8085186          DOI: 10.1111/tbed.13907

Source DB:  PubMed          Journal:  Transbound Emerg Dis        ISSN: 1865-1674            Impact factor:   5.005


  107 in total

1.  Construction and analysis of a human-chimpanzee comparative clone map.

Authors:  Asao Fujiyama; Hidemi Watanabe; Atsushi Toyoda; Todd D Taylor; Takehiko Itoh; Shih-Feng Tsai; Hong-Seog Park; Marie-Laure Yaspo; Hans Lehrach; Zhu Chen; Gang Fu; Naruya Saitou; Kazutoyo Osoegawa; Pieter J de Jong; Yumiko Suto; Masahira Hattori; Yoshiyuki Sakaki
Journal:  Science       Date:  2002-01-04       Impact factor: 47.728

2.  Isolation of SARS-CoV-2-related coronavirus from Malayan pangolins.

Authors:  Kangpeng Xiao; Junqiong Zhai; Yaoyu Feng; Niu Zhou; Xu Zhang; Jie-Jian Zou; Na Li; Yaqiong Guo; Xiaobing Li; Xuejuan Shen; Zhipeng Zhang; Fanfan Shu; Wanyi Huang; Yu Li; Ziding Zhang; Rui-Ai Chen; Ya-Jiang Wu; Shi-Ming Peng; Mian Huang; Wei-Jun Xie; Qin-Hui Cai; Fang-Hui Hou; Wu Chen; Lihua Xiao; Yongyi Shen
Journal:  Nature       Date:  2020-05-07       Impact factor: 49.962

3.  Middle East respiratory syndrome coronavirus (MERS-CoV) causes transient lower respiratory tract infection in rhesus macaques.

Authors:  Emmie de Wit; Angela L Rasmussen; Darryl Falzarano; Trenton Bushmaker; Friederike Feldmann; Douglas L Brining; Elizabeth R Fischer; Cynthia Martellaro; Atsushi Okumura; Jean Chang; Dana Scott; Arndt G Benecke; Michael G Katze; Heinz Feldmann; Vincent J Munster
Journal:  Proc Natl Acad Sci U S A       Date:  2013-09-23       Impact factor: 11.205

4.  Clinical findings in 111 cases of influenza A (H7N9) virus infection.

Authors:  Hai-Nv Gao; Hong-Zhou Lu; Bin Cao; Bin Du; Hong Shang; Jian-He Gan; Shui-Hua Lu; Yi-Da Yang; Qiang Fang; Yin-Zhong Shen; Xiu-Ming Xi; Qin Gu; Xian-Mei Zhou; Hong-Ping Qu; Zheng Yan; Fang-Ming Li; Wei Zhao; Zhan-Cheng Gao; Guang-Fa Wang; Ling-Xiang Ruan; Wei-Hong Wang; Jun Ye; Hui-Fang Cao; Xing-Wang Li; Wen-Hong Zhang; Xu-Chen Fang; Jian He; Wei-Feng Liang; Juan Xie; Mei Zeng; Xian-Zheng Wu; Jun Li; Qi Xia; Zhao-Chen Jin; Qi Chen; Chao Tang; Zhi-Yong Zhang; Bao-Min Hou; Zhi-Xian Feng; Ji-Fang Sheng; Nan-Shan Zhong; Lan-Juan Li
Journal:  N Engl J Med       Date:  2013-05-22       Impact factor: 91.245

5.  A pneumonia outbreak associated with a new coronavirus of probable bat origin.

Authors:  Peng Zhou; Xing-Lou Yang; Xian-Guang Wang; Ben Hu; Lei Zhang; Wei Zhang; Hao-Rui Si; Yan Zhu; Bei Li; Chao-Lin Huang; Hui-Dong Chen; Jing Chen; Yun Luo; Hua Guo; Ren-Di Jiang; Mei-Qin Liu; Ying Chen; Xu-Rui Shen; Xi Wang; Xiao-Shuang Zheng; Kai Zhao; Quan-Jiao Chen; Fei Deng; Lin-Lin Liu; Bing Yan; Fa-Xian Zhan; Yan-Yi Wang; Geng-Fu Xiao; Zheng-Li Shi
Journal:  Nature       Date:  2020-02-03       Impact factor: 69.504

6.  Treatment With Lopinavir/Ritonavir or Interferon-β1b Improves Outcome of MERS-CoV Infection in a Nonhuman Primate Model of Common Marmoset.

Authors:  Jasper Fuk-Woo Chan; Yanfeng Yao; Man-Lung Yeung; Wei Deng; Linlin Bao; Lilong Jia; Fengdi Li; Chong Xiao; Hong Gao; Pin Yu; Jian-Piao Cai; Hin Chu; Jie Zhou; Honglin Chen; Chuan Qin; Kwok-Yung Yuen
Journal:  J Infect Dis       Date:  2015-07-21       Impact factor: 5.226

Review 7.  In Vitro and Animal Models for SARS-CoV-2 research.

Authors:  Kazuo Takayama
Journal:  Trends Pharmacol Sci       Date:  2020-05-30       Impact factor: 14.819

8.  Lung pathology of fatal severe acute respiratory syndrome.

Authors:  John M Nicholls; Leo L M Poon; Kam C Lee; Wai F Ng; Sik T Lai; Chung Y Leung; Chung M Chu; Pak K Hui; Kong L Mak; Wilina Lim; Kin W Yan; Kwok H Chan; Ngai C Tsang; Yi Guan; Kwok Y Yuen; J S Malik Peiris
Journal:  Lancet       Date:  2003-05-24       Impact factor: 79.321

9.  Baloxavir treatment of ferrets infected with influenza A(H1N1)pdm09 virus reduces onward transmission.

Authors:  Leo Yi Yang Lee; Jie Zhou; Rebecca Frise; Daniel H Goldhill; Paulina Koszalka; Edin J Mifsud; Kaoru Baba; Takahiro Noda; Yoshinori Ando; Kenji Sato; Aoe-Ishikawa Yuki; Takao Shishido; Takeki Uehara; Steffen Wildum; Elke Zwanziger; Neil Collinson; Klaus Kuhlbusch; Barry Clinch; Aeron C Hurt; Wendy S Barclay
Journal:  PLoS Pathog       Date:  2020-04-15       Impact factor: 6.823

10.  Engineering the Live-Attenuated Polio Vaccine to Prevent Reversion to Virulence.

Authors:  Ming Te Yeh; Erika Bujaki; Patrick T Dolan; Matthew Smith; Rahnuma Wahid; John Konz; Amy J Weiner; Ananda S Bandyopadhyay; Pierre Van Damme; Ilse De Coster; Hilde Revets; Andrew Macadam; Raul Andino
Journal:  Cell Host Microbe       Date:  2020-04-23       Impact factor: 21.023

View more
  21 in total

1.  Overview of Nonhuman Primate Models of SARS-CoV-2 Infection.

Authors:  Anita M Trichel
Journal:  Comp Med       Date:  2021-09-21       Impact factor: 0.982

Review 2.  Mechanistic Understanding of Lung Inflammation: Recent Advances and Emerging Techniques.

Authors:  Chrysi Keskinidou; Alice G Vassiliou; Ioanna Dimopoulou; Anastasia Kotanidou; Stylianos E Orfanos
Journal:  J Inflamm Res       Date:  2022-06-15

3.  Effects of Spike Mutations in SARS-CoV-2 Variants of Concern on Human or Animal ACE2-Mediated Virus Entry and Neutralization.

Authors:  Yunjeong Kim; Natasha N Gaudreault; David A Meekins; Krishani D Perera; Dashzeveg Bold; Jessie D Trujillo; Igor Morozov; Chester D McDowell; Kyeong-Ok Chang; Juergen A Richt
Journal:  Microbiol Spectr       Date:  2022-05-31

Review 4.  Molecular characteristics, immune evasion, and impact of SARS-CoV-2 variants.

Authors:  Cong Sun; Chu Xie; Guo-Long Bu; Lan-Yi Zhong; Mu-Sheng Zeng
Journal:  Signal Transduct Target Ther       Date:  2022-06-28

Review 5.  Animal models for studying COVID-19, prevention, and therapy: Pathology and disease phenotypes.

Authors:  Shambhunath Choudhary; Isis Kanevsky; Lindsay Tomlinson
Journal:  Vet Pathol       Date:  2022-04-22       Impact factor: 3.157

Review 6.  Animal Hosts and Experimental Models of SARS-CoV-2 Infection.

Authors:  Cristina Parolin; Sara Virtuoso; Marta Giovanetti; Silvia Angeletti; Massimo Ciccozzi; Alessandra Borsetti
Journal:  Chemotherapy       Date:  2021-03-26       Impact factor: 2.544

Review 7.  Host Diversity and Potential Transmission Pathways of SARS-CoV-2 at the Human-Animal Interface.

Authors:  Hayden D Hedman; Eric Krawczyk; Yosra A Helmy; Lixin Zhang; Csaba Varga
Journal:  Pathogens       Date:  2021-02-08

Review 8.  An Overview of SARS-CoV-2 and Animal Infection.

Authors:  Mohamed A A Mahdy; Waleed Younis; Zamzam Ewaida
Journal:  Front Vet Sci       Date:  2020-12-11

9.  A single intranasal or intramuscular immunization with chimpanzee adenovirus-vectored SARS-CoV-2 vaccine protects against pneumonia in hamsters.

Authors:  Traci L Bricker; Tamarand L Darling; Ahmed O Hassan; Houda H Harastani; Allison Soung; Xiaoping Jiang; Ya-Nan Dai; Haiyan Zhao; Lucas J Adams; Michael J Holtzman; Adam L Bailey; James Brett Case; Daved H Fremont; Robyn Klein; Michael S Diamond; Adrianus C M Boon
Journal:  Cell Rep       Date:  2021-06-29       Impact factor: 9.995

10.  Immunogenicity and Safety of an Inactivated SARS-CoV-2 Vaccine: Preclinical Studies.

Authors:  Ahmed Kandeil; Ahmed Mostafa; Rehab R Hegazy; Rabeh El-Shesheny; Ahmed El Taweel; Mokhtar R Gomaa; Mahmoud Shehata; Marawan A Elbaset; Ahmed E Kayed; Sara H Mahmoud; Yassmin Moatasim; Omnia Kutkat; Noha N Yassen; Marwa E Shabana; Mohamed GabAllah; Mina Nabil Kamel; Noura M Abo Shama; Mohamed El Sayes; Amira N Ahmed; Zahraa S Elalfy; Bassim Msa Mohamed; Safa N Abd El-Fattah; Hazem Mohamed El Hariri; Mona Abdel Kader; Osama Azmy; Ghazi Kayali; Mohamed A Ali
Journal:  Vaccines (Basel)       Date:  2021-03-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.